BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4967360)

  • 1. [Ulcero-necrotic purpura revealing Kahler's disease, with macroglobulinemia].
    Bureau Y; Barrière H; Senelar R; Litoux P; Bureau B
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(4):495-8. PubMed ID: 4967360
    [No Abstract]   [Full Text] [Related]  

  • 2. [Macroglobulinemia during a case of Kahler's disease].
    Bureau Y; Senelar R; Barrière H; Bureau B; Litoux P; Bray B
    Presse Med (1893); 1968 Apr; 76(20):961-4. PubMed ID: 4967209
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ophthalmoplegia revealing Kahler's disease].
    Ardouin M; Urvoy M; Eon JY; Le Blay R
    Bull Soc Ophtalmol Fr; 1978 Dec; 78(12):897-9. PubMed ID: 755570
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lichenoid and necrotic purpura with macroglobulinemia and cryoglobulinemia].
    Kuske H
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(4):444-5. PubMed ID: 4973686
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of Kahler's disease].
    Foa J; Carcassonne Y
    Sem Hop; 1976 Jan; 52(3):165-71. PubMed ID: 186874
    [No Abstract]   [Full Text] [Related]  

  • 6. [Kahler's disease].
    Tsouderos Y
    Rev Infirm; 1980 Jun; 30(6):26-30. PubMed ID: 6770447
    [No Abstract]   [Full Text] [Related]  

  • 7. Familial myeloma.
    Boga M; Jákó J; Domán J; Magyar E; Konyár E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(3):201-12. PubMed ID: 4130618
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ulceronecrotic purpura revealing Waldenström's macroglobulinemia].
    Retornaz F; Monestier S; Richard MA; Seux V; Grob JJ; Soubeyrand J
    Presse Med; 2001 Jun; 30(20):1007. PubMed ID: 11433686
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current treatment of Kahler's disease and Waldenström's macroglobulinemia].
    Seligmann M; Meshaka G
    Sem Ther; 1965; 41(6):373-5. PubMed ID: 4964847
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathogenesis of purpura in Waldenstrom's disease].
    Welke S; Mauch H; Altmeyer P
    Verh Dtsch Ges Inn Med; 1978; (84):194-6. PubMed ID: 105493
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gougerot's trisymptom disease with severe necrotic lesions manifesting as Waldenström's cryomacroglobulinemia].
    Degos R; Touraine R; Clauvel JP; Audebert G
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):323-5. PubMed ID: 4995021
    [No Abstract]   [Full Text] [Related]  

  • 12. [Multiple myeloma and other plasma cell dyscrasias].
    del Potro Gómez E; Morales Sanz D
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():52-7. PubMed ID: 10422451
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of the melphalan and of the cyclophosphamide in the treatment of Kahler's disease].
    Bontoux D; Chenbit D; Delbarre F
    Therapeutique; 1971 Jan; 47(1):27-32. PubMed ID: 5572915
    [No Abstract]   [Full Text] [Related]  

  • 14. [Amylosis of the nerve in Kahler's disease].
    Buge A; Escourolle R; Poisson M; Rancurel G; Hauw JJ
    Ann Med Interne (Paris); 1974 Apr; 125(4):359-63. PubMed ID: 4433098
    [No Abstract]   [Full Text] [Related]  

  • 15. Steroid therapy of multiple myeloma and macroglobulinemia.
    Hoogstraten B
    Med Clin North Am; 1973 Sep; 57(5):1321-30. PubMed ID: 4366516
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience on the use of l-phenylalanin nitrogen mustard (melphalan)].
    Artigas L; Dondo Lascano F; Seoane MR; Sagasta C
    Prensa Med Argent; 1970 Mar; 57(3):142-8. PubMed ID: 4989273
    [No Abstract]   [Full Text] [Related]  

  • 17. [Skin lesions as a rare initial symptom of Kahler's disease].
    van Tol KM; Fedder G
    Ned Tijdschr Geneeskd; 1994 Mar; 138(10):526-8. PubMed ID: 8139713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grand rounds: Multiple myeloma.
    Va Med; 1976 Aug; 103(8):585-92. PubMed ID: 983275
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prognosis of Kahler's disease in patients treated and not treated with alkylating agents (apropos of 45 cases)].
    Saporta L; Hugon C; Rondier J; Bontoux D; Delbarre F
    Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):11-8. PubMed ID: 5079686
    [No Abstract]   [Full Text] [Related]  

  • 20. [The problem of interpretation of "atypical" dysglobulinemias. (Apropos of 4 cases treated in a dermatology department)].
    Thivolet J; Perrot H; Pellerat J; Mallein R
    Sem Hop; 1967 Jan; 43(2):107-13. PubMed ID: 4291738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.